(Y49) Psychotropic drugs, not elsewhere classified

More details coming soon

Icon
41 630 in individuals diagnosis psychotropic drugs, not elsewhere classified confirmed
Icon
2 424 deaths with diagnosis psychotropic drugs, not elsewhere classified
Icon
6% mortality rate associated with the disease psychotropic drugs, not elsewhere classified

Diagnosis psychotropic drugs, not elsewhere classified is diagnosed Women are 41.95% more likely than Men

12 083

Men receive the diagnosis psychotropic drugs, not elsewhere classified

710 (5.9 %)

Died from this diagnosis.

100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
29 547

Women receive the diagnosis psychotropic drugs, not elsewhere classified

1 714 (5.8 %)

Died from this diagnosis.

Risk Group for the Disease psychotropic drugs, not elsewhere classified - Men aged 15-19 and Women aged 20-24

Icon
In Men diagnosis is most often set at age 5-9, 15-29, 35-54, 65-79
Icon
Less common in men the disease occurs at Age 0-5, 10-14, 30-34, 55-64, 80-95+Less common in women the disease occurs at Age 0-5, 80-84, 90-95+
Icon
In Women diagnosis is most often set at age 5-79, 85-89

Disease Features psychotropic drugs, not elsewhere classified

Icon
Absence or low individual and public risk
Icon

Psychotropic drugs, not elsewhere classified - what does this mean

Psychotropic drugs, not elsewhere classified, are medications that affect the brain and nervous system, altering mood, behavior, and cognitive function. these drugs are used to treat a variety of mental health disorders, including anxiety, depression, bipolar disorder, and schizophrenia. they work by influencing the levels of neurotransmitters in the brain, which can help to regulate emotions and behavior.

What happens during the disease - psychotropic drugs, not elsewhere classified

Psychotropic drugs, not elsewhere classified, act on the nervous system to alter mood and behavior. they can affect the neurotransmitters in the brain to reduce anxiety, depression, and other mental health issues. the drugs can also affect the way the brain processes information, leading to altered thinking and behavior. in some cases, they can cause physical side effects such as nausea, dizziness, and fatigue. long-term use of these drugs can increase the risk of addiction and other serious health problems.

Clinical Pattern

More details coming soon

How does a doctor diagnose

  • Physical examination
  • Blood tests
  • Urine tests
  • Psychological evaluation
  • Brain imaging
  • Neuropsychological testing
  • Genetic testing

Treatment and Medical Assistance

Main goal of the treatment: To reduce the symptoms of the disease.
  • Prescription of psychotropic drugs
  • Psychotherapy
  • Cognitive-behavioral therapy
  • Family therapy
  • Group therapy
  • Meditation and relaxation techniques
  • Exercise
  • Nutrition and dietary changes
  • Stress management
  • Sleep hygiene
  • Social support
Icon
10 Days of Hospitalization Required
Icon
Average Time for Outpatient Care Not Established

Psychotropic drugs, not elsewhere classified - Prevention

More details coming soon

Specified forms of the disease

(Y49.0) Tricyclic and tetracyclic antidepressants
(Y49.1) Monoamine-oxidase-inhibitor antidepressants
(Y49.2) Other and unspecified antidepressants
(Y49.3) Phenothiazine antipsychotics and neuroleptics
(Y49.4) Butyrophenone and thioxanthene neuroleptics
(Y49.5) Other antipsychotics and neuroleptics
(Y49.6) Psychodysleptics [hallucinogens]
(Y49.7) Psychostimulants with abuse potential
(Y49.8) Other psychotropic drugs, not elsewhere classified
(Y49.9) Psychotropic drug, unspecified